Navigation Links
Fatal respiratory infections in endangered gorillas are linked to human contact
Date:3/30/2011

In a study published online this week in the journal Emerging Infectious Diseases, an international team of researchers report that a virus that causes respiratory disease in humans infected and contributed to the deaths of mountain gorillas in Virunga National Park. This finding raises questions about the safety of ecotourism for endangered species.

The study, which appears in the April issue of the journal, was conducted by scientists at Columbia University's Center for Infection and Immunity (CII), Roche 454 Life Sciences, the UC Davis Wildlife Health Center and the Mountain Gorilla Veterinary Project, a US-based non-profit organization.

Mountain gorillas (Gorilla beringei beringei) live primarily in Rwanda, Uganda and the Democratic Republic of Congo in Bwindi Impenetrable National Park and Virunga National Park, which houses about a third of the world's remaining gorilla population. Despite international efforts to protect this endangered species, there are currently fewer than 800 living mountain gorillas in the world.

Now, this study, which focuses on an outbreak of respiratory disease in the Hirwa group of mountain gorillas in 2009, suggests that these animals may also be susceptible to human pathogens. Infectious diseases, especially respiratory ones, are the second leading cause of sudden deaths among mountain gorillas, after poaching.

Growing ecotourism has increased interactions between humans and wild animals living in these parks, intensifying the chance for disease transmission. While ecotourism has heightened awareness of the need to safeguard endangered species, world travel also has the potential to quickly spread disease.

Local authorities have recently tried to reduce animals' exposure to potentially harmful pathogens by limiting the number of tourists visiting wildlife parks and requiring visitors to wear protective masks. Despite these efforts, the frequency and severity of respiratory disease outbreaks among gorillas have been on the rise. In fact, of the 12 gorillas in the Hirwa group, 11 showed classic symptoms of respiratory infection, including coughing, runny nose and lethargy. Two of these gorillas, an adult female and her male infant, died.

Using state-of-the-art molecular methods, CII researchers found evidence of respiratory tract infection with human metapneumovirus (HMPV) and bacterial pneumonia in the female's lungs, throat and nose.

Further tests confirmed that HMPV found in the lungs of sick gorillas was closely related to strains circulating in South Africa, over 1,000 miles away, suggesting that tourists may have carried the virus into the parks.

'Pure' HMPV infections typically result only in mild damage to the respiratory system, suggesting that an interaction between HMPV and bacterial pneumonia may have been the cause of death. This observation is consistent with other studies that have shown that respiratory viruses like HMPV and H1N1, can make hosts more susceptible to opportunistic infections, like pneumonia.

CII investigator and first author, Gustavo Palacios, stated, "we usually think of viruses as jumping from wildlife to humans, but what we often don't realize is that this is a two-way highway."

"This study illustrates the importance of global commitment to the One Health Initiative," commented CII Director, Dr. W. Ian Lipkin. The One Health Initiative is a movement whose aim is to promote collaboration among environmental, agricultural, veterinary and human health sectors. Says Dr. Lipkin, "Conservation efforts must be expanded to protect wild animals from human pathogens to which they likely lack immunity."


'/>"/>

Contact: Daniela Hernandez
dfh2101@columbia.edu
Columbia University's Mailman School of Public Health
Source:Eurekalert

Related medicine news :

1. Fans of Winning Teams Linked to Fatal Crashes
2. Obesity Alone Raises Risk of Fatal Heart Attack, Study Finds
3. Increasingly, Other Ailments Prove Fatal for People With COPD
4. WSU researchers apply fatigue model to fatal commuter air crash
5. For the Very Obese, H1N1 Was More Apt to Be Fatal
6. Nerve Tissue Cancer More Often Fatal for Non-White Kids
7. Scientists seek urgent treatment for fatal sleeping sickness
8. Fatalistic Attitudes May Keep Hispanic Women From Cancer Tests
9. Global media campaign finds hidden children with rare, fatal aging disorder
10. Stem Cell Treatment May Offer Hope Against Fatal Skin Disorder
11. 2010 Tornado Season ends with lower fatalities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... , ... July 26, 2017 , ... Team Type 1 ... to medicine for everyone affected by diabetes, is excited to announce the 106 college ... Ambassador Program. , Established in 2005, the Team Type 1 Foundation has bestowed ...
(Date:7/26/2017)... (PRWEB) , ... July 26, 2017 , ... ... dogs and cats has opened in Jupiter. The state of the art ... and class leading treatments with a goal of providing heart patients longer lives. ...
(Date:7/26/2017)... ... 2017 , ... Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) ... development of pharmaceutical and consumer products, announces the operational numbers of its wholly-owned ... International LLC recorded unaudited fiscal Q1 profits of $897,596 based on revenues of ...
(Date:7/26/2017)... ... 2017 , ... Wendy M. Musielak, a partner at the Andrew Cores Family Law ... Association’s third Vice President earlier this year. She will serve the membership in this capacity ... President, in accordance with the organization’s by-laws. , Musielak joined the Andrew ...
(Date:7/26/2017)... ... July 26, 2017 , ... The number of adults 65 years or ... ways to improve asthma control in the population are not well described. In a ... Practice), an official journal of the American Academy of Allergy, Asthma & Immunology (AAAAI), ...
Breaking Medicine News(10 mins):
(Date:7/27/2017)... EXTON, Pa., July 27, 2017  West Pharmaceutical Services, ... financial results for the second-quarter 2017 and updated financial ... Second-Quarter 2017 Highlights Reported ... 2.5% over the prior-year quarter. Net sales at constant ... 2017 reported-diluted EPS was $0.51, compared to $0.60 in ...
(Date:7/25/2017)... BARCELONA, Spain and CAMBRIDGE, Massachusetts ... SOM Biotech, specializing in repurposing drugs to treat rare nervous ... Therapeutics Inc. to clinically develop and market the drug SOM0226 ... reached, the drug achieved very promising results in a Phase ... A new office in the United ...
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July 21, 2017 ... ) announced today that it will report its second ... Thursday, July 27, 2017. ... July 27, 2017, at 9:00 a.m. Eastern Time.  The ... dialing 1-970-315-0533.  A rebroadcast of the teleconference will be ...
Breaking Medicine Technology: